4//SEC Filing
Zoghbi Huda Y 4
Accession 0001708138-22-000024
CIK 0000872589other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 4:14 PM ET
Size
8.2 KB
Accession
0001708138-22-000024
Insider Transaction Report
Form 4
Zoghbi Huda Y
Director
Transactions
- Exercise/Conversion
Common Stock
2022-03-16$391.92/sh+2,000$783,840→ 3,082 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2022-03-16−2,000→ 2,117 totalExercise: $391.92Exp: 2026-09-09→ Common Stock (2,000 underlying) - Sale
Common Stock
2022-03-16$675.00/sh−2,000$1,350,000→ 1,082 total
Footnotes (2)
- [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- [F2]The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
Documents
Issuer
REGENERON PHARMACEUTICALS, INC.
CIK 0000872589
Entity typeother
Related Parties
1- filerCIK 0001681643
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 4:14 PM ET
- Size
- 8.2 KB